The store will not work correctly when cookies are disabled.
6-[(2-(Trifluoromethyl)benzyl)thio]-9H-purine
ID: ALA4776786
PubChem CID: 129733003
Max Phase: Preclinical
Molecular Formula: C13H9F3N4S
Molecular Weight: 310.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1ccccc1CSc1ncnc2[nH]cnc12
Standard InChI: InChI=1S/C13H9F3N4S/c14-13(15,16)9-4-2-1-3-8(9)5-21-12-10-11(18-6-17-10)19-7-20-12/h1-4,6-7H,5H2,(H,17,18,19,20)
Standard InChI Key: UWBRROCBSQQQBQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
30.5071 -11.6057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5059 -12.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2140 -12.8342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2122 -11.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9208 -11.6021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9256 -12.4207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7056 -12.6692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1830 -12.0041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6979 -11.3447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2097 -10.3797 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.5008 -9.9732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7943 -10.3839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0892 -9.9766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3832 -10.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3852 -11.2047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0991 -11.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8021 -11.1986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0882 -9.1594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7954 -8.7500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.3800 -8.7516 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.0805 -8.3411 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
13 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 310.30 | Molecular Weight (Monoisotopic): 310.0500 | AlogP: 3.66 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.54 | CX LogP: 3.42 | CX LogD: 3.42 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.59 | Np Likeness Score: -1.47 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |